We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ResMed Inc | NYSE:RMD | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.02 | 0.48% | 215.01 | 217.30 | 211.36 | 212.65 | 1,307,035 | 00:49:04 |
HMEs applaud “huge time-saver” auto-enroll feature
Managing compliance for sleep apnea patients and increasing resupply revenue just got easier for home medical equipment (HME) providers, as Brightree today announced automated resupply enrollment for patients managed by both Brightree and AirView™ by ResMed (NYSE: RMD).
Now when AirView alerts the Brightree® Connect resupply program that a patient has achieved compliance on positive airway pressure (PAP) therapy, the patient can be automatically enrolled into the Connect resupply program, saving the HME time, increasing their resupply revenue and most important, ensuring that every PAP user is getting the best therapy experience possible. This feature is available to HMEs that have integrated their Brightree Connect and ResMed AirView accounts.
“This is a huge time-saver for us,” said Mindy Carlton, HME business manager at Deaconess Home Medical in Evansville, Indiana. “This kind of automation helps us grow our resupply business and provide great patient care.”
Automated resupply enrollment is the latest in a growing list of features for HMEs using Brightree and AirView, the world’s largest remote monitoring network with more than 5 million patients. These other features also aim to maximize both patient and HME benefits:
“Automation is the key to driving a smarter, faster healthcare system and ultimately healthier patients,” said Matt Mellott, Brightree president and CEO. “We’re excited to give HMEs the power of automated resupply enrollment to increase their efficiency and revenues, and most important, ensure that every patient gets the supplies they need for the best possible therapy experience.”
About Brightree
Brightree, a wholly-owned subsidiary of ResMed (NYSE: RMD), is the leading provider of cloud-based software to improve clinical and business performance of post-acute care companies. Ranked one of the top 100 healthcare IT companies in the U.S., Brightree serves more than 2,200 organizations in the HME, home health, hospice, orthotic and prosthetic, HME pharmacy, home infusion and rehabilitation home care segments. For more information, visit http://www.brightree.com or call 1.888.598.7797.
Brightree is a registered trademark of Brightree LLC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170912005503/en/
BrightreeFor media:Eric Lucey, 678-243-7986elucey@brightree.comorFor investors:Agnes Lee, 858-836-5971investorrelations@resmed.com
1 Year ResMed Chart |
1 Month ResMed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions